ASX RELEASE 12 October 2026 Expiry of PAROB Listed Options – Company in Voluntary Administration Paradigm Biopharmaceuticals Ltd (Administrators Appointed) (ASX:PAR) (“Paradigm” or “the Company”), advises that 116,360,866 quoted options, trading under the ASX Code PAROB...
Expiry of PAROB Listed Options
Filed with ASX · · 2 pages · English
Release
Paradigm Biopharmaceuticals Ltd. on 6ix
Earlier from Paradigm Biopharmaceuticals
- Notification of cessation of securities - PAR
- Update on Data Review and Convertible note redemption
- Continuation of Suspension from Quotation
- Appointment of Voluntary Administrators
- Board Initiates Voluntary Administration
Later from Paradigm Biopharmaceuticals
- PPS Shows Significant Pain Benefit in Rest of World Analysis
- Further Agreed Convertible Note Redemption
- Extension of Convening Period
- Deferral of AGM and Financial Reporting Obligations
- Convening Period Extended to 27 January 2027
Follow Paradigm Biopharmaceuticals into a list and get an email when it puts out news.
Follow Paradigm Biopharmaceuticals